Literature DB >> 33584211

The Physiological Significance of A-Waves in Early Diabetic Neuropathy: Assessment of Motor Nerve Fibers by Neurophysiological Techniques.

Qiong Cai1,2, Guliqiemu Aimair1,2, Wen-Xiao Xu1,2, Pei-Yao Xiao1,2, Lie-Hua Liu3, Yin-Xing Liang1,2, Chao Wu1,2, Song-Jie Liao1,2.   

Abstract

Objective: This study aimed to investigate how early A-waves could occur in type II diabetes, and what it implied functionally.
Methods: We performed conduction velocity distribution (CVD) test in peroneal nerves of 37 type II diabetic patients with normal nerve conduction study (NCS) and 22 age-matched controls. The electrophysiological data and clinical information were analyzed.
Results: A-waves were observed in 45.9% of diabetic patients and only in 1 person in healthy controls, all detected in the tibial nerves. The diabetic patients with A-waves showed faster conduction velocity in all quartiles in the motor peroneal nerves compared to the patients without A-waves, and their CVD histograms were shifted to the right side, consisting of a significantly larger percentage of fast conducting fibers. There was no significant difference in the CVD values of the upper extremity nerves among the patients with and without A-waves and the healthy controls.
Conclusion: A-waves could occur in type II diabetes as early as when NCS showed normal, and represented as a sign of neuropathy as well as a sign of rescued motor nerve function.
Copyright © 2021 Cai, Aimair, Xu, Xiao, Liu, Liang, Wu and Liao.

Entities:  

Keywords:  A-waves; conduction velocity distribution; diabetic neuropathy; nerve conduction studies; type II diabetes

Year:  2021        PMID: 33584211      PMCID: PMC7876338          DOI: 10.3389/fnsys.2021.633915

Source DB:  PubMed          Journal:  Front Syst Neurosci        ISSN: 1662-5137


  37 in total

Review 1.  Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms.

Authors:  Soroku Yagihashi; Shin-Ichiro Yamagishi; Ryuichi Wada
Journal:  Diabetes Res Clin Pract       Date:  2007-04-26       Impact factor: 5.602

2.  F-wave latencies in patients with diabetes mellitus.

Authors:  Hua Pan; Fan Jian; Jinxi Lin; Na Chen; Chunfang Zhang; Zaiqiang Zhang; Zeyu Ding; Yongjun Wang; Liying Cui; Jun Kimura
Journal:  Muscle Nerve       Date:  2014-01-27       Impact factor: 3.217

3.  F wave, A wave, H reflex, and blink reflex.

Authors:  Nivedita Jerath; Jun Kimura
Journal:  Handb Clin Neurol       Date:  2019

4.  Partial peripheral motor nerve lesions induce changes in the conduction properties of remaining intact motoneurons.

Authors:  L A Havton; J R Hotson; J O Kellerth
Journal:  Muscle Nerve       Date:  2001-05       Impact factor: 3.217

5.  Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score.

Authors:  J W G Meijer; A J Smit; E V Sonderen; J W Groothoff; W H Eisma; T P Links
Journal:  Diabet Med       Date:  2002-11       Impact factor: 4.359

6.  An early diagnostic tool for diabetic neuropathy: conduction velocity distribution.

Authors:  Seckin Tuncer; Nizamettin Dalkilic; Haci Hasan Esen; Mustafa Cihat Avunduk
Journal:  Muscle Nerve       Date:  2011-02       Impact factor: 3.217

7.  Use of collision tests to identify physiological differences between the median and ulnar nerves.

Authors:  Magdalena Koszewicz; Mariusz Szydlo; Jerzy Gosk; Malgorzata Wieczorek; Slawomir Budrewicz
Journal:  Muscle Nerve       Date:  2019-02-11       Impact factor: 3.217

8.  A Waves in Diabetic Neuropathy: Pathophysiology and Neurographic Images.

Authors:  Liborio Rampello; Luigi Rampello; Antonio Arcidiacono
Journal:  J Clin Neurophysiol       Date:  2019-03       Impact factor: 2.177

Review 9.  [Diabetic polyneuropathy].

Authors:  D Ziegler
Journal:  Internist (Berl)       Date:  2020-03       Impact factor: 0.743

Review 10.  Diabetic Neuropathy: A Position Statement by the American Diabetes Association.

Authors:  Rodica Pop-Busui; Andrew J M Boulton; Eva L Feldman; Vera Bril; Roy Freeman; Rayaz A Malik; Jay M Sosenko; Dan Ziegler
Journal:  Diabetes Care       Date:  2017-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.